Wegovy FlexTouch: the UK facts behind a name that causes real confusion

The biggest myth: that 'FlexTouch' is a Wegovy-specific product you can request by name

A question our prescribers hear most weeks is some version of: "Can I specifically get the FlexTouch pen for my Wegovy?" The confusion is understandable. Novo Nordisk uses the FlexTouch name on their Ozempic pen (the diabetes formulation of semaglutide) and because Ozempic and Wegovy share the same active ingredient, searches and forum posts blur the two product lines constantly.

Wegovy has its own pen device family, distinct from the Ozempic FlexTouch. The Wegovy pens used in the UK across the titration schedule (from the 0.25 mg starting dose through to 2.4 mg) are pre-filled single-dose auto-injectors that you dial, press and dispose of each week. They are not branded FlexTouch. If you have seen FlexTouch referenced on a box or a patient information leaflet, it is worth checking whether that document relates to Ozempic or to a different Novo Nordisk product; the two are prescribed for different indications and should not be used interchangeably.

This distinction matters medically, not just administratively. Ozempic is licensed for type 2 diabetes in the UK, not for weight management, as the NHS medicines page for semaglutide sets out clearly. Using Ozempic off-label for weight loss sits outside the protections of a licensed indication and outside the clinical pathway a regulated prescriber would follow.

What pen device actually delivers Wegovy, and how the 7.2 mg approval changed the picture

The Wegovy titration schedule in the UK runs from 0.25 mg up through 0.5 mg, 1.0 mg, 1.7 mg and 2.4 mg, with each step guided by the prescriber at roughly four-week intervals. Each dose was historically supplied as an individual pre-filled pen. In January 2026 Novo Nordisk introduced 7.2 mg as a higher maintenance dose (initially delivered as three 2.4 mg pens used in a single week) before the MHRA approved a dedicated single-dose 7.2 mg pen on 14 April 2026. That newer pen has a built-in covered needle and locks automatically after use, which addresses one of the handling questions people raise about the earlier format.

The pen you actually receive is determined by your current prescribed dose and what the dispensing pharmacy has in licensed supply. If you are exploring treatment options and want to understand the full semaglutide landscape, the semaglutide overview on this site covers how the medicine works and what the clinical evidence shows. For a closer look at the Wegovy injection specifically and how it compares with other treatment pathways, the Wegovy treatment page goes into further detail.

No regulated UK pharmacy should be confirming a specific pen format before a clinical consultation has taken place. Stock, dose and device are confirmed at the dispensing stage, not at the point of browsing.

Injection technique: what matters most, regardless of pen format

The pen device is a delivery mechanism. What determines how well semaglutide is absorbed (and how comfortable each injection feels) is technique, not brand. Subcutaneous injections for Wegovy go into the abdomen, the outer thigh, or the upper arm; rotating sites week to week reduces localised reactions. Some people find the skin around the injection site more sensitive than usual in the first weeks of treatment, which is discussed in detail on the semaglutide skin sensitivity page.

Before each injection, let the pen reach room temperature for a few minutes if it has been in the fridge. The Wegovy SmPC on the electronic Medicines Compendium sets out the exact storage window for keeping a pen at room temperature before use, always check the Patient Information Leaflet in the box rather than relying on a number quoted online, because guidance can change between product batches. Inject slowly and hold the pen in place for a few seconds after the click. If you are concerned about getting the dose right, your prescriber or aftercare team can walk you through it.

One practical note on cost context: private Wegovy prescriptions in the UK are priced per pen, and the dose you are on directly affects what you pay month to month. The weight-loss treatment overview sets out the broader pricing landscape and what a complete service should include beyond the pen itself.

How to access Wegovy through a regulated UK prescriber

Wegovy is a prescription-only medicine, so the legal route is a clinical consultation with a qualified prescriber who can assess whether it is appropriate for you. NHS access exists through specialist weight management services under NICE technology appraisal TA875, though waiting lists vary significantly by area. Privately, regulated online pharmacies offer a faster route for people who meet the licensed eligibility criteria and want to avoid a wait.

When choosing an online service, verifying the pharmacy on the GPhC register is the single most important check you can make. Counterfeit semaglutide pens have been seized in large numbers by MHRA enforcement, and the pen device (whether FlexTouch or any other format) is impossible to verify visually if it has come through an unlicensed channel. A supply route that bypasses clinical assessment is a red flag, not a convenience. If you have questions about how the consultation process works, the FAQ page covers the most common ones, and the about us page explains the clinical oversight behind the service.

If you are ready to see whether Wegovy is clinically appropriate for you, start your free consultation, a GPhC-registered prescriber reviews it the same day.